Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

NCT00276549 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: gemcitabine hydrochloride

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]